Simcere Zaiming, Inc.
CIK: 0002080252
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (100.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NXTC
NextCure, Inc.
Discretionary Trading P&L
Holdings
About Simcere Zaiming, Inc.
Simcere Zaiming, Inc. (SEC CIK 0002080252) files insider reports with the SEC as NextCure, Inc. (NXTC).
Signal8 holds 3 ownership filings by Simcere Zaiming, Inc. (2 Form 3, 1 Form 4), filed between Aug 19, 2025 and Aug 12, 2026. Those filings report 1 transaction, the latest on Aug 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Simcere Zaiming, Inc.'s filings is in CAMBRIDGE, MA.
Recent filings by Simcere Zaiming, Inc.
- Aug 10, 2026: Open-market sale of NXTC shares (Form 4, code S).
Other insiders filing for NextCure, Inc. (NXTC)
- ADAR1 Capital Management, LLC, 10% Owner
- Feigal Ellen, Director
- Jones Elaine V, Director
- Borgman Anne Elizabeth, Director
- Webster Stephen W, Director
- KABAKOFF DAVID S, Director